SAB Biotherapeutics, Inc. Warrant
SABSW
SABSW
7 hedge funds and large institutions have $28.1K invested in SAB Biotherapeutics, Inc. Warrant in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
2
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$3K
Top Buyers
| 1 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$349 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LP
1
LMR Partners
London,
United Kingdom
| $18.8K | – | – | – |
|
2
Morgan Stanley
New York
| $3.81K | – | – | – |
|
|
YCM
3
Yakira Capital Management
Westport,
Connecticut
| $2.35K | -$433 | -14,497 | -16% |
|
|
HWM
4
HB Wealth Management
Atlanta,
Georgia
| $2.09K | +$349 | +9,999 | +20% |
|
5
Walleye Trading
New York
| $828 | -$179 | -6,900 | -18% |
|
|
WAM
6
Wolverine Asset Management
Chicago,
Illinois
| $161 | -$141 | -4,035 | -47% |
|
|
NA
7
NewEdge Advisors
New Orleans,
Louisiana
| $28 | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| – | -$122 | -1,633 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$4 | -48 | Closed |
|